Observational studyJournal of managed care & specialty pharmacy2023

Clinical and economic outcomes in patients with chronic obstructive pulmonary disease initiating maintenance therapy with tiotropium bromide/olodaterol or fluticasone furoate/umeclidinium/vilanterol.

Sanjay Sethi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.